drug
Indapamide Teva
Marketedupdated 3mo agoby Teva Pharmaceuticals USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Indapamide Teva
- N/ARapid Management of Resistant Hypertension in the Public Health System (Fast Control)
- phase2Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)
- —Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)
- phase3Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
- phase3Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
- phase3A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
- phase3To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil
- phase1Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that